Cargando…
Response to Pneumococcal Polysaccharide Vaccination in HIV-Positive Individuals on Long Term Highly Active Antiretroviral Therapy
BACKGROUND AND OBJECTIVES: Streptococcus pneumoniae continues to cause serious infections in HIV-positive individuals in the era of highly active anti-retroviral therapy. This led to the recommendation to revaccinate HIV-positive individuals with PPV23 five years after primary vaccination. The benef...
Autores principales: | Iyer, Anita S, Leggat, David J, Ohtola, Jennifer A, Duggan, Joan M, Georgescu, Claudiu A, Al Rizaiza, Adeeb A, Khuder, Sadik A, Khaskhely, Noor M, Westerink, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405245/ https://www.ncbi.nlm.nih.gov/pubmed/25908996 http://dx.doi.org/10.4172/2155-6113.1000421 |
Ejemplares similares
-
Response to Pneumococcal Polysaccharide Vaccination in Newly Diagnosed HIV-Positive Individuals
por: Leggat, David J, et al.
Publicado: (2015) -
Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults
por: Iyer, Anita S., et al.
Publicado: (2016) -
Immune response to pneumococcal polysaccharides 4 and 14 in elderly and young adults. I Antibody concentrations, avidity and functional activity
por: Kolibab, Kris, et al.
Publicado: (2005) -
Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020) -
Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)